Cutting-Edge Liposome Innovations for Precision Delivery and Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 116
Special Issue Editors
Interests: nanomedicine; toxicity; antitumor activity; molecular image; preclinical studies; citotoxicity
Special Issue Information
Dear Colleagues,
Liposomes were discovered in the 1960s by Alec Bangham and have since been widely used in the field of pharmaceutical technology. Their use for drug targeting and tumour therapy were major breakthroughs in the field of medicine. Recently, studies have pointed to the use of these nanostructures with some functionalization models such as imaging agents, targeting of specific tissues, co-delivery of drugs, or genetic material encapsulation for the treatment of several cancer models.
In this issue, we aim to present the latest articles, recent advances, and state-of-the-art in targeting and cancer therapy involving liposomes.
Dr. Sued Eustáquio Mendes Miranda
Prof. Dr. Anna Eliza Maciel de Faria Mota Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- cancer therapy
- targeted delivery
- chemotherapy
- nanomedicine
- functionalized nanoparticle
- controlled release liposome
